[Translation] A randomized, double-blind, placebo-controlled, multicenter, Phase 3 study evaluating the efficacy and safety of once-daily induction therapy with ABX464 in subjects with moderately to severely active ulcerative colitis
主要目的是比较ABX464与安慰剂在临床缓解方面的有效性。
[Translation] The primary objective is to compare the effectiveness of ABX464 with placebo in terms of clinical remission.